"An impactful Circulating Tumor Cells (CTC) Liquid Biopsy Market research report provides a comprehensive overview of the market, taking into consideration factors such as product definition, vendor landscape, and market segmentation. Currently, businesses heavily rely on the diverse segments covered in the market research report, gaining valuable insights to steer their operations in the right direction. The competitive analysis sheds light on market share and actions taken by key industry players, empowering businesses to make informed decisions on strategies that yield maximum return on investment (ROI).
This steadfast Circulating Tumor Cells (CTC) Liquid Biopsy Market research report imparts knowledge on all the aforementioned factors through a transparent, extensive, and high-quality market study. To achieve this, every crucial aspect of the market research analysis—ranging from market definition, segmentation, competitive analysis, major market developments, to top-notch research methodology—has been meticulously considered in formulating this report. Moreover, the Circulating Tumor Cells (CTC) Liquid Biopsy Market business report is the result of the dedicated efforts of an innovative, enthusiastic, knowledgeable, and experienced team of analysts, researchers, industry experts, and forecasters.
The essential factors contributing to the growth of the circulating tumor cells (CTC) liquid biopsy market in the forecast period of 2023-2030 include the growing demand of circulating tumor cells (CTC) liquid biopsy because of their effectiveness, increasing prevalence of cancer due to various genetic disorders, increasing alcohol consumption, and lifestyle changes.
Explore Further Details about This Research Circulating Tumor Cells (CTC) Liquid Biopsy Market Report https://www.databridgemarketresearch.com/reports/global-circulating-tumor-cells-ctc-liquid-biopsy-market
Circulating Tumor Cells (CTC) Liquid Biopsy Market Scope and Segmentation
REPORT METRIC | DETAILS |
Forecast Period | 2023 to 2030 |
Base Year | 2022 |
Historic Years | 2021 (Customizable to 2015-2020) |
Quantitative Units | Revenue in USD Million, Volumes in Units, Pricing in USD |
Segments Covered | Technology (CTC Detection Methods, CTC Enrichment Methods, Ex Vivo Positive Selection, Molecular (RNA)-Based Technologies, Functional In Vitro Cell Invasion Assay, Xenotransplantation Models, Microchips, Single Spiral Microchannel, Negative Selection Immunocytochemical Technologies), Application (Cancer Application, Non-Cancer Applications, Non-Invasive Prenatal Testing (NIPT), Organ Transplantation, Infectious Disease Testing), Clinical Application (Early Cancer Screening, Diagnosis, Therapy Selection, Treatment Monitoring, Prognosis and Recurrence Monitoring), Sample Type, (Blood, Urine, Saliva, Cerebrospinal Fluid, Others), Product (Kits Reagents, Blood Collection Tubes, Devices or System), Specimen (Blood, Bone Marrow, Other Body Fluids), End User (Research Academic Institutes, Reference Laboratories Hospitals Physician Laboratories) |
Countries Covered | U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America. |
Market Players Covered | QIAGEN (Germany), Bio-Techne (U.S.), Precision Medical Group, LLC. (U.S.), Aviva Systems Biological Corporation (U.S.), Biocept, Inc. (U.S.), Fluxion Biosciences, Inc. (U.S.), Greiner Bio-One International GmbH (Austria) , Ikonisys (U.S.), Miltenyi Biotec (Germany), IVDiagnostics (U.S.), BioFluidica (U.S.), Canopus Medical (Sweden), Biolidics Limited (Singapore), Creativ MicroTech, Inc. (U.S.), LungLife AI, Inc. (U.S.), Epic Sciences (U.S.), Rarecells Diagnostics (France), ScreenCell (France), Menarini Silicon Biosystems (U.S.). |
Market Opportunities |
|
Market Definition
The liquid biopsy is a type of non-invasive blood test which identifies circulating tumor cells and tumor DNA fragments which are released in the blood by primary tumors and metastatic sites. It is an alternative to surgical biopsy procedure, and it allows surgeon to detect cancer at a very early stage. The circulating tumor cells function as a seed of metastases. The patients who have developed solid tumors it is found in them. The detection and quantification of tumor cells in the blood of cancer patients is allowed by the testing of circulating tumor cells. There are various types of biological phenotypes of circulating tumor cells (CTCs) such as stem cell-like or mixed, mesenchymal or epithelial. These phenotypes are present in blood in a very small quantity and due to which, a phase of isolation-enrichment is required in their detection.
Global Circulating Tumor Cells (CTC) Liquid Biopsy Dynamics
Drivers
- Rising prevalence of cancer
The rising prevalence of different types of cancer is boosting the market’s growth. The increasing number of cancer cases across the world is fuelling the demand of liquid biopsy. Breast cancer was the most common cancer 2020 with 2.26 million cases and further lung cancer with 2.21 million cases. The rising prevalence of cancer can be reduced through early detection of cancer and appropriate treatment. Circulating cancer cells are suitable for developing preclinical models, particularly 3D organoid cultures, for use in drug screening, disease modelling, genome editing, and organoid biobanks, thus significantly driving the market’s growth.
- Awareness initiatives by global health organizations and government
The governments in various countries and global health organizations are spreading awareness about cancer and other growing diseases. National Cancer Control program of WHO, is a public health program aiming to reduce the growing number of cancer deaths and improve the life of cancer patients. Furthermore, the National Breast and Cervical Cancer Early Detection Program (NBCCEDP), initiated by the US Centers for Diseases and Prevention (CDC) in 1991, provides breast cancer screening and diagnosis for uninsured and low-income patients in the US every year. The rising awareness in people about the effects and necessity to cure the diseases is increasing the liquid biopsy tests and treatments further driving the market’s growth.
Opportunities
- Growth opportunities in emerging countries
The developing countries such as India, Brazil, Turkey, Russia, South Africa, China, South Korea are offering major growth opportunities for liquid biopsy market. The major factors owing to the growth of liquid biopsy market in developing economies include improving healthcare infrastructure, higher cancer prevalence, large patient population, increasing disposable income, and growing medical tourism. Thus, there are number of opportunities for the market’s growth.
- Increasing RD associated with liquid biopsy
The new research and development in liquid biopsies have revolutionized several related technologies, clinical oncology, devising personalized therapeutic regimens, offering easy tumor sampling, continuous monitoring by repeated sampling, and screening for therapeutic resistance. The increasing research and development is further increasing the demand of liquid biopsy which further increases the market’s growth.
Report Investment: Know the Pros
- Besides assessing real time developments and triggers, this section of the report also presents notable past highlights that accelerated growth in this Circulating Tumor Cells (CTC) Liquid Biopsy Market
- A well scouted presentation of all the crucial segments that collectively harness maximum profit building in global Circulating Tumor Cells (CTC) Liquid Biopsy Market
- A detailed account of crucial Circulating Tumor Cells (CTC) Liquid Biopsy Market developments, potential investment bays as well as evaluation of successful business decisions that guide profitable business outcome
- A clear depiction of Circulating Tumor Cells (CTC) Liquid Biopsy Market specific dynamics, competitor analysis as well as gauging competition intensity
Browse Related Reports:
Infliximab Market Is Likely to Upsurge at Billion Globally by Size, Share, Trends, Demand, Growth and Opportunity Analysis
https://www.databridgemarketresearch.com/reports/global-infliximab-market
Dupuytren's Disease Market Size worth Billion Globally by Size, Share, Trends, Demand, Revenue Growth and Competitive Outlook
https://www.databridgemarketresearch.com/reports/global-dupuytrens-disease-market
BRCA1 and BRCA2 Genes Market to Observe Prominent CAGR Growth by 2Size, Share, Trends, Demand, Market Growth and Competitive Analysis
https://www.databridgemarketresearch.com/reports/global-brca1-and-brca2-genes-market
Heart Valve Devices Market To Perceive Highest CAGR Growth by Size, Share, Trends, Key Drivers, Growth Opportunities and Revenue Analysis
https://www.databridgemarketresearch.com/reports/global-heart-valve-devices-market
Virology Testing Market to Perceive Prominent Growth of Billion by Size, Share, Trends, Demand, Growth and Competitive Analysis
https://www.databridgemarketresearch.com/reports/global-virology-testing-market
Hematology Analyzer Market Forecasted to Exhibit an Incredible Growth of Billion by Size, Share, Trends, Key Drivers, Demand and Opportunity Analysis
https://www.databridgemarketresearch.com/reports/global-hematology-analyzer-market
Healthcare Reimbursement Market Anticipated to Garner Significant Growth of Billion By Size, Share, Trends, Opportunities, Key Drivers, and Revenue Forecast
https://www.databridgemarketresearch.com/reports/global-healthcare-reimbursement-market
Healthcare/Medical Simulation Market Poised to Achieve Exponential CAGR Growth by Size, Share, Trends, Opportunities, Key Drivers, and Revenue Forecast
https://www.databridgemarketresearch.com/reports/global-healthcare-medical-simulation-market
Optometry/Eye Exam Equipment Market to Notice Prominent CAGR Growth by Size, Share, Trends, Demand, Growth and Competitive Outlook
https://www.databridgemarketresearch.com/reports/global-optometry-eye-exam-equipment-market
Plasma Therapy Market to Observe Utmost Growth of Billion by Size, Share, Trends, Demand, Key Players and Growth Factors
https://www.databridgemarketresearch.com/reports/global-plasma-therapy-market
About Data Bridge Market Research:
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Email – [email protected]
"
